Docking studies of molecules with PfA-M1 alanyl-aminopeptidase
M1 alanyl-aminopeptidase (PfA-M1) is a potential target for the treatment of malaria. With increase in resistance against most antimalarial drug it is now imperative to find new drug target M1 alanyl aminopeptidase. . The PfA- M1 crystal structure was retrieved from protein data bank. Fifteen (15) ligands, obtained from screening were docked with PfA-M1 using AUTODOCK. The binding affinity of these ligands was compared with that of Bestatin. Interestingly, some of the compounds showed very similar or better docking scores as compared to bestatin which is a natural inhibitor of m1 fa. These selected compounds can be further studied for developing potential inhibitors against PfA-M1.
Results
So, I docked 15 ligand with M1 alanyl-aminopeptidase (PfA-M1) 3d structure model I got the 10 conformation for single ligand and reported best confirmations with their binding energy and docking score.